Candriam SCA’s TRACON Pharmaceuticals TCON Stock Holding History
Bought
Maintained
Sold
Other funds holding TCON
6CM
TI
Candriam SCA's TCON Position: Q4 2018 in Review
Candriam SCA sold out of TRACON Pharmaceuticals (TCON) in Q4 2018, closing a stake of 715 shares — an estimated $293K sold.
Candriam SCA first reported a position in TCON in Q1 2015 and held it in 14 quarters. The position peaked at $1.76M in Q1 2015. 27 funds tracked by Wall St. Rank hold TCON as of Q4 2018.
- Candriam SCA reported no remaining TRACON Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
- Candriam SCA sold 715 TRACON Pharmaceuticals shares in Q4 2018, an estimated $293K.
- Candriam SCA first reported a position in TRACON Pharmaceuticals in Q1 2015 and held it in 14 quarters.
- Candriam SCA's TRACON Pharmaceuticals position peaked at $1.76M in Q1 2015.
- 27 funds tracked by Wall St. Rank held TRACON Pharmaceuticals as of Q4 2018.
Based on Candriam SCA's 13F filing for Q4 2018, filed 14 Feb 2019.